Scott M. Pittman, Director, 10% Owner at Nuo Therapeutics, Inc. (AURX), bought 2,045,000 shares at $0.22 ($607K) on 2017-08-10, disclosed to the SEC on 2017-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.22 | 1,485,000 | $327K | 53.8% |
| 2 | $0.50 | 560,000 | $280K | 46.2% |
| Total | $0.30 avg | 2,045,000 | $607K | 100% |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateNuo Therapeutics, Inc. | BUY | 2016-07-29 | $825K | — | Filing → |